Abbott India Limited operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Abbott India Limited with three other
companies in this sector in INDIA :
Alembic Pharmaceuticals Ltd
sales of 46.06 billion Indian Rupees [US$609.80 million]
of which 85%
IPCA Laboratories Limited
(46.49 billion Indian Rupees [US$615.49 million]
Glaxosmithkline Pharmaceuticals Limited
(32.24 billion Indian Rupees [US$426.91 million]
During the year ended March of 2020, sales at
Abbott India Limited were 40.93 billion Indian Rupees (US$541.93 million).
increase of 11.3%
versus 2019, when the company's sales were 36.79 billion Indian Rupees .
This was the fifth consecutive year of sales increases at Abbott India Limited
(and since 2015, sales have increased a total of 79%).